Hired and Retired: Stick with experience or twist?
The longer the time spent in the industry, the greater the reputation built and this is reflected in this month’s appointments.
One appointment sees Sanofi bring in a new head of development with a strong reputation built on several years at R&D powerhouses, such as Genentech and Amgen.
Another sees an experienced individual given another chance, after being unceremoniously shown the door at a fledgling biotech after claims of ‘personal misconduct’.
In contract, LEO Pharma has opted for a change of leadership that sees Gitte Aabo scheduled to leave the company after 27 years.